Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Rapid Dose Therapeutics Corp
C.DOSE
Alternate Symbol(s):
RDTCF
Cannabis
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. The Company provides disruptive drug delivery technologies designed to improve patient outcomes. The Company’s flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into...
the bloodstream, resulting in rapid onset of the active ingredient. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product. The Company also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:DOSE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(5)
•••
bajanjohn
X
View Profile
View Bullboard History
Post by
bajanjohn
on Apr 14, 2021 11:22am
NEWS WOW
Big news and 315 shares traded.......The same 10,000 shares get trdeded every other day or so. The Volume spikes here are wild (lol) When will they actually get some product using "quickstrip
...more
(6)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Mar 17, 2021 1:05pm
RE:Look at this junk, needs a reverse split ASAP
Now that's stupid
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(0)
•••
TNArocker
X
View Profile
View Bullboard History
Post by
TNArocker
on Mar 16, 2021 12:16pm
Look at this junk, needs a reverse split ASAP
Dead stock until then
(6)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Mar 12, 2021 10:42am
RE:RE:RE:A good start
Acquisition of a company apparently for desperately needed 3 mil cash. Manufacturing for a third party due to lack of production of proprietary products. Seemingly no sales and marketing. If I wasn
...more
(5)
•••
bajanjohn
X
View Profile
View Bullboard History
Comment by
bajanjohn
on Mar 12, 2021 9:46am
RE:RE:A good start
I could not agree with you more. A revolutionary product should be a no brainer for a company like Apotex to do a white label painkiller or a smaller company. ( would love to see one of the big boys
...more
(6)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Mar 11, 2021 12:45pm
RE:A good start
Nice plan however execution doesn't seem to be happening. Surely such a revolutionary product should be able to find a market. Seems not.
(6)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Mar 11, 2021 12:39pm
RE:RE:RE:Instant sales
Neither does OG labs. Successful marketing apparently works. Dose should try it.
(5)
•••
bajanjohn
X
View Profile
View Bullboard History
Comment by
bajanjohn
on Mar 11, 2021 11:25am
RE:RE:Instant sales
I don't think that there is to much wrong with making money.
(6)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Mar 11, 2021 10:09am
RE:Instant sales
Utilizing obviously available production capacity to manufacture successful products for others just means sales of proprietary products (ie strips) is a failure. This isn't good news, just riding
...more
(5)
•••
bajanjohn
X
View Profile
View Bullboard History
Post by
bajanjohn
on Mar 11, 2021 8:40am
A good start
This is extremly positive news. Now if we can get a similar arrangement on quickstrips with an established phamacuetical company for mass market consumer product (pain relief, or flu/cold relief) we
...more
(1941)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Mar 10, 2021 8:39pm
Instant sales
"We have experienced demand from Canadians on our website that we were unable to fulfill. Through RDT, we can now make our popular aftermarket pods and disposable vaporizers available to Canadian
...more
(6)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Mar 09, 2021 2:37pm
RE:RE:RE:RE:Buyout is good news
Sales and marketing given the same priority as timely financials. Don't hold your breath.
(5)
•••
bajanjohn
X
View Profile
View Bullboard History
Comment by
bajanjohn
on Mar 08, 2021 11:47am
RE:RE:RE:Buyout is good news
Now that the deal has closed, they can concentrate on getting their "STRIP" technology into many more white label products. I hope that they are try to partner with some large pharmaceutical
...more
(6)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Feb 01, 2021 10:54am
RE:RE:Buyout is good news
Seems you're alone, Just buying cash.
(1)
•••
Corvetteman
X
View Profile
View Bullboard History
Comment by
Corvetteman
on Jan 30, 2021 2:52pm
RE:Buyout is good news
I'm very optamistic on DOSE, this is an exceptional time to buy in or buy more. It takes some time to report the steps taken forward by DOSE, be patient.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer